Pharmaceutical preparation manufacturing federal obligations in Pennsylvania (NAICS 325412)

What the 325412–Pennsylvania join is

NAICS 325412 and geography PA meet here. $923,137,640.30 is the USAspending.gov obligation sum on awards that carry both tags. It is not the nationwide pharma-prep book, not Pennsylvania’s entire federal inflow, and not an outlay. Wholesale, PBM, and retail pharmacy codes sit elsewhere.

693 awards is a moderate manufacturing list beside $923,137,640.30. A mid-size row count can still hold a large commitment if a few preparation vehicles dominate. The packet does not name FDA, vaccines, or a branded label inside the 693 records. Those names are ordinary speech, not extra dollars.

Open Pennsylvania federal spending for every industry tagged to the state, NAICS 325412 for 325412 without a Pennsylvania filter, Pennsylvania industries for other Pennsylvania NAICS pairs, and All spending ties for joins outside this preparation-manufacturing cell. Do not add those parents into $923,137,640.30.

A finished-dose book, not a drugstore tally

Dividing $923,137,640.30 by 693 awards yields about $1.33 million per award. That mean is a ratio, not a typical Philadelphia fill-finish line and not a typical Pittsburgh plant order. Unique recipients are unpublished. 693 is not a count of SKUs, lots, or pharmacies.

Pennsylvania geography invites an eastern-corridor story. This extract does not split Philadelphia, Lancaster, or Pittsburgh. All share PA inside $923,137,640.30. Treating the cell as one named manufacturer’s Pennsylvania budget adds a label the facts do not carry.

Nationwide 325412 without a Pennsylvania overlay is a different total

The national industry hub aggregates 325412 across every state. Pennsylvania’s statewide hub aggregates every NAICS with a PA tag. Only awards that carry both 325412 and Pennsylvania place of performance belong here, which is why this page cites 693 awards and $923,137,640.30.

Place of performance can follow a payee address, in-state work, or a reporting convention. 325412 awards coded to New Jersey, New York, or Maryland do not enter this sum even if a vendor’s mailroom sits in Philadelphia. The join cannot re-allocate dollars along a Mid-Atlantic pharma chain.

Obligations, not outlays, on the Pennsylvania 325412 cell

An obligation is a legal commitment. An outlay is a payment. $923,137,640.30 is the former. This packet has no outlay total and no fiscal-year split. Citing the figure as doses already shipped from Pennsylvania over-reads the field. 693 remains an award-record count, not a lot count and not a prescription tally.

What the Pennsylvania–325412 pair does not prove

A large pharmaceutical-preparation total in Pennsylvania does not mean the code caused the state’s drug-plant mix, and it does not connect these obligations to campaign contributions. Correlation is not causation. Approvals, shortages, and list prices are not USAspending columns here.

Keep $923,137,640.30 labeled as NAICS 325412 obligations with Pennsylvania place of performance. Pennsylvania federal spending still includes wholesale and PBM codes that must not be folded into this factory cell. NAICS 325412 is 325412 without the state filter. Pennsylvania industries lists sibling Pennsylvania codes.

How to cite pharma preparation in Pennsylvania

A clean footnote names NAICS 325412 (pharmaceutical preparation manufacturing), Pennsylvania place of performance, $923,137,640.30 in obligations, and 693 awards on USAspending.gov. Keep the obligation word. Mean dollars per action remain about $1.33 million. Do not per-plant the total; a facility census is unpublished. All spending ties indexes other pairs. A later ingest can restate $923,137,640.30 without changing the join of 325412 and PA.

Wholesale drug, PBM, and retail-pharmacy NAICS are not this preparation-manufacturing cell. Pennsylvania federal spending still mixes every Pennsylvania industry; do not quote that parent as 325412. NAICS 325412 is the national factory code without the Pennsylvania tag. Pennsylvania industries keeps sibling Pennsylvania chemical codes unmerged. 693 is a record count, including modifications, not a unique-plant census. Keep the obligation label on $923,137,640.30 in every reuse. Correlation is not causation. Readers who reuse PA pharma manufacturing | USAspending $923.1M should keep both sides of the join in the same sentence, cite USAspending.gov as the source, and treat award rows as records rather than unique vendors. The live hubs linked from this page can refresh the snapshot; this narrative does not invent a fiscal year, a recipient list, or an outlay total that the packet omitted. Place of performance remains a geography tag, not proof that work stayed inside the named state.

Questions

How much has NAICS 325412 obligated in Pennsylvania?

USAspending.gov records $923,137,640.30 in obligations for NAICS 325412 with Pennsylvania place of performance, covering 693 awards. That is an obligation aggregate for the pharma-prep–Pennsylvania pair, not an outlay figure and not the nationwide 325412 total. Original filings remain on USAspending.gov.

Is this Pennsylvania pharmacy-benefit spending?

No. NAICS 325412 is pharmaceutical preparation manufacturing, not PBM or retail pharmacy. $923,137,640.30 covers 693 awards with Pennsylvania place of performance under that factory code. PBM and wholesale books have their own NAICS pages. Quote 325412 and Pennsylvania together.

Does place of performance mean the drugs were made in Pennsylvania?

Not necessarily. Pennsylvania is a USAspending geography tag on awards that also carry NAICS 325412. Work or later modifications can occur elsewhere. $923,137,640.30 is not proof that every dose was manufactured in-state. Original filings remain on USAspending.gov.

Where are the live Pennsylvania and 325412 tables?

Pennsylvania federal spending shows all industries in the state. NAICS 325412 shows NAICS 325412 without a state filter. Pennsylvania industries lists other Pennsylvania industry pairs. All spending ties lists joins outside this cell. Prefer those hubs after later USAspending ingests.